Paws for a Moment: Recognizing and Treating Shock in Small Animals

Shock is a life-threatening condition in which oxygen consumption by the tissues exceeds oxygen delivery. If left untreated, this inadequate perfusion leads to cellular energy deficit, organ dysfunction, and eventual organ failure.^1,2 Shock is not a singular diagnosis but a clinical sign of more significant underlying disease or a massive, acute insult (Table 1).

Oxygen delivery depends on many factors (Figure 1). Dysfunction in 1 or more of these factors can lead to shock; for example, decreased preload from vomiting secondary to parvovirus or increased preload, increased afterload, and decreased contractility in congestive heart failure. Conversely, many of these factors also represent action steps for the veterinarian in addressing shock. Intravenous fluid therapy increases preload in the parvoviral patient, while diuretics, vasodilators, and inotropes decrease preload, decrease afterload, and improve contractility, respectively, in the patient with congestive heart failure.

Figure 1. Factors contributing to oxygen delivery (“tree of life”).

Classification of Shock in Dogs and Cats

Multiple schemes exist for classifying shock, but the most widely accepted and clinically useful approach divides shock into 4 principal categories: hypovolemic, cardiogenic, obstructive, and distributive. These groups are based on underlying mechanistic derangements in circulatory function and provide a framework for both understanding and ultimately managing patients presenting with shock in veterinary practice.

Hypovolemic Shock

Hypovolemic shock arises from a reduction in effective circulating blood volume such that preload to the heart decreases and the resulting cardiac output is insufficient for tissue oxygen delivery.³ This decrease can involve the loss of whole blood (hemorrhagic shock), plasma-like fluid (e.g., exudative loss), or crystalloid-like fluid (vomiting, diarrhea, polyuria). Hypovolemic shock may be further subclassified as absolute (external) loss of fluid or blood from the vascular compartment or relative loss, as seen with marked third-spacing of fluids into body cavities or interstitial compartments.

In both dogs and cats, hypovolemic shock is the most frequently encountered subtype in primary and emergency care settings.⁴ In response, compensatory neurohumoral activation (increased sympathetic outflow, catecholamine release, vasopressin and renin–angiotensin–aldosterone system [RAAS] activation) attempts to restore perfusion to vital organs, primarily the brain and heart. If hypovolemia remains uncorrected, the patient moves to a decompensated phase marked by failure of these mechanisms; progressive tissue hypoxia; metabolic acidosis; microvascular dysfunction; and, ultimately, cardiopulmonary arrest or multiorgan failure and death.

Cardiogenic Shock

Cardiogenic shock occurs when the heart fails as a pump such that effective forward flow is markedly reduced despite normal or even increased blood volume. This shock type is primarily the result of intrinsic myocardial dysfunction, severe arrhythmias, or valvular incompetence.^5,6

The pathophysiology of cardiogenic shock is dominated by intrinsic cardiac pathology resulting in decreased cardiac output. Most commonly this is the result of failing myocardium and a drop in stroke volume. As cardiac output falls, arterial pressure and organ perfusion drop, triggering baroreceptor-mediated sympathetic activation. While this increases systemic vascular resistance in an effort to preserve central blood pressure, the elevated afterload further impairs cardiac performance, creating a vicious cycle. Additionally, any increase in filling pressures exacerbates pulmonary or systemic congestion.

In both cats and dogs, but particularly in cats, the onset can be abrupt, and underlying cardiac diseases (including previously undiagnosed conditions) should always be considered in any animal presenting with shock and a suggestive medical history. The distinction from other types of shock is crucial, as the primary defect is not the vasculature or circulating volume but rather the heart itself; thus, therapy must avoid aggressive volume resuscitation, which may precipitate or worsen pulmonary edema.

Arrhythmias can result in shock even without underlying alterations to cardiac structure. As noted in Figure 1, heart rate is a contributor to cardiac output. With tachyarrhythmias, end-diastolic volume is decreased due to reduced ventricular filling time secondary to the elevated rate. In bradyarrhythmias, stroke volume may be preserved or occasionally increased, but the severely impaired rate decreases cardiac output.

Obstructive Shock

Obstructive shock is defined by a physical impediment to blood flow, resulting in insufficient cardiac filling or outflow and downstream tissue hypoperfusion. In obstructive shock, the heart’s intrinsic function is preserved, but mechanical barriers restrict venous return (preload) or ventricular ejection (afterload).^7,8 For instance, in gastric dilatation–volvulus, the distended stomach compresses the caudal vena cava (CVC), sharply reducing venous return and subsequently cardiac output. In cardiac tamponade, fluid or air accumulating within the pericardial sac impairs diastolic filling, acting as an obstruction and ultimately causing precipitous hemodynamic collapse; emergent pericardiocentesis is definitive for restoration of cardiac performance. Obstructive shock also includes rarer etiologies such as pleural space diseases (e.g., large-volume effusions, tension pneumothorax, tension pneumomediastinum), which additionally impair pulmonary function.

The critical feature distinguishing obstructive shock from hypovolemic or cardiogenic forms is reversibility with mechanical relief of the obstruction: decompression, thoracocentesis, or surgical intervention can restore function if performed in a timely manner.

Distributive Shock

Distributive shock is characterized by a pathologic loss of systemic vascular tone, leading to maldistribution of blood flow and relative hypovolemia despite normal overall blood volume.

In distributive shock due to inflammatory or infectious disease, inflammatory mediators (e.g., cytokines, nitric oxide, histamine) disrupt vascular smooth muscle tone and increase endothelial permeability.^1,9 This results in vasodilation, pooling of blood in the periphery, and leakage of plasma into the interstitial space, all of which compromise central circulatory volume and microvascular perfusion. Notably, while cardiac output may initially rise in response to decreased afterload, this is often insufficient, and as distributive shock evolves, myocardial depression and hypovolemia caused by third-spacing worsen the perfusion deficit.

Distributive shock may also result from lack of response to normal hormones and neurotransmitters. This can include conditions such as maldistribution, as cortisol is important for regulation of normal vasomotor tone.

Mixed Shock States

It is essential to recognize that animals may present with mixed shock states. For instance, septic and anaphylactic patients may develop both distributive and hypovolemic shock due to gastrointestinal fluid loss or effusion, while cardiac tamponade can lead to both obstructive and secondary cardiogenic dysfunction with myocardial ischemia. A keen understanding of these overlapping mechanisms is central to successful clinical management.

Clinical Presentation of Shock

The clinical manifestations of shock in dogs and cats are highly variable and depend on both the underlying cause and the duration of circulatory compromise. Evaluation relies on appraisal of the entire patient, as no single historical clue or physical examination parameter is pathognomonic for shock or sufficient to delineate the specific classification.

In practice, the assessment of shock centers on an integrated evaluation of several core perfusion parameters: mentation, heart rate, pulse quality, mucous membrane color, capillary refill time (CRT), and temperature. These features, along with ancillary findings such as shock index (SI), lactate, and point-of-care ultrasonography results, provide the clinician with critical insight into the severity and trajectory of shock in the emergent setting.

Compensatory Shock

Compensatory shock is the earliest phase and is characterized by effective activation of neurohormonal mechanisms aimed at preserving perfusion to vital organs. Sympathetic stimulation increases heart rate, myocardial contractility, and systemic vascular resistance, while activation of the RAAS and vasopressin promotes vasoconstriction and fluid retention. As a result, blood pressure is often maintained within the normal range or may even be transiently increased despite a reduction in effective circulating volume or cardiac output.

Clinically, patients may exhibit tachycardia, mildly prolonged or even rapid (<1 second) CRT, and cool peripheral tissues, while mentation remains normal or mildly anxious. Pulse palpation often reveals strong or bounding pulses. It should be noted that early in distributive shock, mucous membranes may be red or injected (versus pale pink) due to systemic vasodilation causing peripheral venous pooling of blood.

Early Decompensated Shock

Early decompensated shock occurs when compensatory mechanisms begin to fail and are no longer sufficient to maintain adequate tissue perfusion. During this phase, blood pressure may be mildly to moderately decreased; however, perfusion deficits become clinically apparent. Patients typically develop weak pulses, worsening CRT, altered mentation, and decreased urine output, accompanied by progressive metabolic acidosis and rising lactate concentrations. This stage represents a critical window in which timely, targeted intervention can still reverse the shock state.

Late Decompensated Shock

Late decompensated shock reflects failure of both hemodynamic compensation and cellular metabolism due to depletion of adenosine triphosphate, with widespread tissue injury and organ dysfunction. Profound myocardial depression, loss of vascular tone, and severe microcirculatory failure result in markedly reduced cardiac output and hypotension that is often refractory to therapy. Cellular hypoxia leads to mitochondrial dysfunction, inflammatory mediator release, coagulopathy, and progressive multiorgan failure.

Clinically, patients may exhibit severe hypotension, bradycardia, hypothermia, depressed mentation or coma, and profound metabolic acidosis with markedly elevated lactate levels. Prognosis at this stage is poor, as shock has progressed beyond primarily hemodynamic derangements to irreversible cellular injury.

Shock in Cats

Feline patients often present with a distinct clinical syndrome, tending to decompensate rapidly or present late in the disease course. Bradycardia, which is atypical in most other species, is often found in cats with even mild to moderate shock, reflecting species-specific baroreceptor and cardiac reflex differences.^1,10 Hypothermia is another hallmark, and even minimally decreased body temperatures in cats should be seen as a grave sign when evaluating for shock. Cats typically display weak or nonpalpable peripheral pulses, marked pallor or muddy mucous membranes, obtunded mentation, hypotension, and cold extremities. Tachycardia, if present, is transient and often progresses rapidly to bradycardia and collapse as decompensation accelerates.

Distinctive Signs

The presenting features of shock may also be shaped by its underlying cause. Classic hypovolemic shock, as seen with hemorrhage or severe dehydration, tends to produce pale mucosae, cool extremities, and tachycardia in dogs and bradycardia in cats, with rapid onset of altered consciousness as severity increases. Cardiogenic and obstructive forms may introduce additional findings, such as jugular distention, heart murmurs, gallop rhythms, arrhythmias, or muffled heart sounds.¹¹ Distributive shock (from sepsis or anaphylaxis) is unique in that the early phase may involve rapid CRT, bounding pulses, and injected mucous membranes, which are features associated with vasodilation, but often progresses to a picture indistinguishable from other shock forms as compensatory mechanisms are exhausted.

Diagnostic Approach to Shock

The presence or absence of any single clinical sign cannot reliably diagnose shock, and misleading findings are common due to concurrent medications, anesthesia, or preexisting disease. Thus, repeated focused assessments and the aggregation of multiple findings over time remain central to effective diagnosis and intervention.

Assessment of patients for shock must balance history, presenting complaint (e.g., trauma, vomiting, collapse), physical findings, and the trajectory of perfusion parameters during serial examinations. A holistic, vigilant clinical approach, recognizing the nuanced species-specific and case-dependent variations, is essential to optimize outcomes for dogs and cats presenting in shock.

Much of the diagnostic approach to the patient in shock focuses on identifying the underlying pathology; few modalities offer the opportunity to definitively diagnose shock or differentiate between the categories. Traditional diagnostics include calculation of SI and measurement of blood lactate concentrations. Point-of-care ultrasonography has become a cornerstone of triage in the emergency department and offers expanded opportunities to assess patients for fluid responsiveness.

Shock Index

The SI, calculated as heart rate divided by systolic blood pressure, offers a rapid, objective, noninvasive tool for evaluating the presence and severity of shock in both dogs and cats. Its main strengths are simplicity, bedside accessibility, and high sensitivity for detecting occult hypoperfusion, even when individual parameters such as heart rate or blood pressure appear normal. An SI of >1 in dogs and >1.54 in cats is typically used to differentiate patients in shock from healthy patients.^10,12

SI increases with worsening shock and correlates with severity, which can prompt early intervention and facilitate serial monitoring during resuscitation. However, the method is not without pitfalls: There is significant individual variation and some overlap with values seen in healthy or mildly ill patients. Therefore, SI should not be used as the sole endpoint for resuscitation or to estimate percentage blood loss. SI values are influenced by factors such as pain, anxiety, drugs, and concurrent disease, and normalization does not necessarily guarantee complete physiologic recovery.¹² Additionally, SI does not provide insight into the type of shock.

Ultimately, SI is best interpreted alongside physical examination findings and other diagnostic markers to strengthen decision making in emergency and critical care settings.

Lactate

Lactate measurement is a valuable tool for detecting tissue hypoperfusion in veterinary patients with suspected shock, providing an objective and sensitive marker that often identifies poor oxygen delivery before hypotension occurs. Serial lactate monitoring is especially useful, as trends can inform prognosis, guide ongoing resuscitation, and help predict outcomes in both trauma and critical illness.

However, reliance on lactate is not without risks: Elevations can result from causes other than hypoperfusion, such as hepatic dysfunction, certain drugs, stress, or neoplasia, and normal lactate levels do not definitively exclude the presence of shock.¹³ Age also plays a factor in interpretation, as neonates (<28 days) use lactate as a primary energy substrate, resulting in higher normal values.14 Therefore, while lactate is a valuable adjunct for diagnosing and managing shock, it must be interpreted alongside clinical findings and other diagnostic parameters to avoid misdirection in therapy or prognostication. Like SI, lactate also does not differentiate between the types of shock.

Point-of-Care Ultrasonography

The caudal vena cava collapsibility index (CVCCI) has been evaluated as a dynamic ultrasound-based measure for predicting fluid responsiveness in critically ill, spontaneously breathing dogs with evidence of hypoperfusion. By calculating the percentage change in the diameter of the CVC during respiration, the CVCCI provides a real-time, noninvasive marker of central blood volume and venous return (Figure 2).

A study found that dogs with a baseline CVCCI >27% were highly likely to respond to fluid therapy, with this threshold demonstrating excellent sensitivity (100%) and good specificity (83.3%).¹⁵ These results indicate that a high CVCCI, reflecting greater CVC collapse during inspiration, is a reliable indicator of hypovolemia and preload dependence. Importantly, the static diameter of the CVC alone was not predictive; respiratory variation was key. The CVCCI method also exhibited strong intra- and interobserver reliability. However, the study authors caution that confounding factors such as increased intra-abdominal pressure, cardiac dysfunction, or abnormal thoracic dynamics may impact readings and that findings should always be interpreted alongside the clinical context. This study supports the inclusion of CVCCI as a promising bedside tool for guiding resuscitation and assessing hypovolemia in small animal emergency medicine.¹⁵ This assessment requires more clinical investigation to determine optimal utilization and requires additional training to develop proficiency.

Figure 2. Calculation of the caudal vena cava collapsibility index (CVCCI). CVCCI = [(CVC_max—CVC_min)/CVC_max]×100. Courtesy credit: Igor Yankin, DVM, DACVECC

Clinical Approach to Shock

Initial assessment and rapid intervention are essential for patients in shock. Often, the veterinary team must make decisions with extremely limited information and use response to therapy as a diagnostic tool.

Ruling Out Cardiogenic Shock

Distinguishing cardiogenic shock from other shock forms is critical to avoid the risk of fluid overload and pulmonary edema. From this standpoint, the clinician’s first goal should be to deprioritize cardiogenic shock as a differential. The clinician must employ a combination of diagnostic cues, including breed, age, and detailed medical history, with particular attention to past or known cardiac disease. Auscultation for heart murmurs, gallop rhythms, arrhythmias, or muffled cardiac sounds (which could indicate pericardial effusion) provides essential data. Jugular venous distention and the presence of pericardial or pleural effusion on ultrasonography further support suspicion for cardiogenic etiologies.¹¹

Rapid imaging, such as bedside thoracic ultrasonography or focused echocardiography, can delineate contractility deficits, chamber enlargement, valvular abnormalities, or the accumulation of fluid in the pericardial sac and should be performed when available. In cats, subtle findings such as abnormalities in gallop rhythm or mild arrhythmias warrant close attention, as underlying cardiomyopathy may be present even in the absence of overt cardiac history. Additionally, the response to a test fluid bolus itself serves as an indirect diagnostic: A dramatic worsening in respiratory effort, auscultatory crackles, or rapid onset of pulmonary edema following fluid administration increases the suspicion for a cardiogenic or volume-overloaded state, prompting immediate cessation and cardiac-focused therapy.

Ultimately, only by integrating history, examination findings, electrocardiography, and select imaging modalities can cardiogenic shock be efficiently ruled out and a safe, systematic resuscitation algorithm confidently implemented.⁶

Actions After Assessment

In general, 3 of the 4 types of shock discussed are fluid tolerant, meaning that the patient’s clinical outcome will not be significantly adversely affected by judicious fluid therapy. Cardiogenic shock is the only form of shock in which intravenous fluid therapy is directly contraindicated. Once cardiogenic shock has been ruled out, an intravenous fluid bolus should be administered. Response to therapy dictates the next steps (Figure 3).

Improvement in vital parameters should cue the clinician to look for a hypovolemic component and assess the patient for obstructive causes of shock. Lack of improvement should raise clinical suspicion for distributive shock. Worsening of clinical signs should trigger the clinician to reassess the patient for potential cardiogenic shock or ongoing significant losses, such as hemorrhage.

Figure 3. Clinical approach to patients in shock.

Treatment of Shock

The primary goal in treating shock is to promptly restore adequate tissue perfusion and oxygen delivery, with therapy tailored to the underlying cause and type of shock. Immediate interventions include securing vascular access, providing supplemental oxygen, and ensuring patient warmth while avoiding unnecessary stress. While the specific therapy may vary based on the type of shock, the tenets of resuscitation remain the same: Therapy should be initiated rapidly and response typically noted within 20 to 30 minutes. This response, whether positive, negative, or neutral, helps to determine the next steps.

Regardless of shock type, successful therapy demands continuous reassessment and adjustment. Restoration of clinical perfusion parameters (e.g., improved mentation, normalized CRT, strong pulses, pink mucous membranes, decreasing lactate) are used as end points to titrate and ultimately guide therapy for the best possible patient outcomes.

Crystalloids

For hypovolemic, obstructive, and distributive shock, isotonic crystalloid fluids are the first-line resuscitative therapy. Dogs typically receive 10- to 20-mL/kg boluses of crystalloids, while cats are generally started at 10mL/kg, with repeated reassessment following each bolus to evaluate the patient’s cardiovascular response. This bolus is administered for 15 to 20 minutes.

Numerous human studies support the use of balanced, buffered, isotonic (e.g., Normosol-R, lactated Ringer’s solution, Plasma-Lyte A) crystalloid solutions versus unbalanced, nonbuffered, and acidic solutions such as 0.9% sodium chloride in critically ill humans; however, there are no large-scale veterinary studies comparing fluid types.^16,17 In the initial stages of resuscitation, measurement of the patient’s electrolytes may not be available; as this information becomes available, fluid composition should be taken into consideration for significant sodium dyscrasias, as some patients may require specific or contrived solutions to prevent changing concentrations too rapidly.

Hypertonic Saline

Hypertonic saline remains an attractive option for volume resuscitation; however, care should be taken to ensure that the patient is not clinically dehydrated, which applies to a large number of veterinary patients in shock. Hypertonic saline may also be specifically indicated in patients with neurologic disease. The high sodium concentration in this crystalloid rapidly pulls water from the extravascular compartment; therefore, fluid deficits in this compartment will result in decreased efficacy. The dose for 7% hypertonic saline is typically 3 to 5 mL/kg in dogs and 2 to 3 mL/kg in cats over 20 minutes.

Colloids

Colloids play an adjunctive role in veterinary shock resuscitation, depending on the underlying reason for shock. Natural colloids, including plasma products and whole blood, can provide oncotic support with albumin and clotting factor replenishment. Synthetic colloids have been more scrutinized in past decades, focusing on the safety profile of products such as hydroxyethyl starch (HES) and succinylated gelatin. Synthetic colloids can provide rapid intravascular volume expansion; however, experimental and clinical work has highlighted potential renal and hemostatic risks, prompting a more conservative approach.

A canine hemorrhagic shock model comparing 6% HES 130/0.4 and 4% succinylated gelatin to fresh whole blood and crystalloids demonstrated that gelatin was associated with larger increases in urinary acute kidney injury (AKI) biomarkers and more frequent tubular microvesiculation than HES, crystalloids, or blood, suggesting product-specific nephrotoxicity rather than a uniform synthetic colloid effect.¹⁸ Two additional studies evaluated HES 130/0.4 exposure in clinical dogs and did not find a higher overall incidence of AKI versus crystalloid-treated controls; however, both studies linked increasing cumulative dose or duration of HES administration with worsening AKI grade, supporting the practice of minimizing dose and limiting use to short time frames during resuscitation.^19,20

A retrospective cohort study associated 10% HES therapy with an increased risk of adverse outcome, including AKI and death, reinforcing concerns raised from human critical care and contributing to current recommendations that synthetic colloids, if used at all, be reserved for select shock patients and used at the lowest effective dose for the briefest possible duration.²¹

Fluid Volume

Volume resuscitation should be dictated by the underlying reason for fluid loss. Crystalloid therapy is the first-line choice for initial efforts in almost all cases but should be used judiciously, especially when hemorrhage is identified. Studies have documented worse outcomes with liberal administration of crystalloids in cases of hemorrhagic shock. In these cases of massive blood loss, crystalloid fluid therapy is ineffective for replacing the oxygen-carrying capacity provided by red blood cells, hemostatic support provided by clotting factors, and oncotic pressure provided by albumin. Large-volume fluid therapy is associated with increased risk for coagulopathy, worsened hypothermia, acidosis, and death.^22,23

Initial stabilization followed by decline should trigger the clinician to evaluate for obstructive etiologies or continued, significant losses (e.g., ongoing intravascular volume loss, hemorrhage). Identification of ongoing bleeding or massive hemorrhage should prompt the clinician to consider blood products.

First-Line Vasopressors

If hypotension remains despite adequate fluid resuscitation and no apparent hemorrhage, adjunctive therapies such as vasopressors may be indicated (Table 2). Norepinephrine is currently considered the first-line vasopressor for distributive shock in veterinary medicine, reflecting both survey data and extrapolation from human sepsis guidelines and owing to its potent vasoconstrictive effects and relatively favorable adverse effect profile.^9,24,25 Dopamine is now less preferred due to a higher risk of arrhythmias and less predictable hemodynamic response in both animal and human studies, though it may still be considered in select cases or when alternatives are not available.²⁶

All vasopressors should be started at the lowest dose, administered intravenously as a constant-rate infusion, and titrated up every 20 to 30 minutes until the patient’s systolic blood pressure is above 90 mm Hg.

Adjunctive Vasopressors

If systolic blood pressure remains below 90 mm Hg despite moderate to high doses of norepinephrine, adjunctive vasopressors such as vasopressin or epinephrine may be added to achieve hemodynamic goals, with vasopressin often used as a second-line agent (Table 2). Ultimately, the combination of targeted fluid therapy, timely initiation of vasopressors, and correction of the underlying etiology is critical to improve survival in animals with distributive shock.

The caveat to this approach is distributive shock secondary to anaphylaxis. While fluid therapy is often indicated in these patients, concurrent intervention with epinephrine (0.01 mg/kg IM) is recommended. Epinephrine’s α-adrenergic properties help increase systemic vascular resistance, while the β-adrenergic effects decrease mast cell degranulation.²⁷ Anaphylactic patients requiring multiple doses of intramuscular epinephrine may benefit from a constant-rate infusion.

Cardiogenic Shock

Management of cardiogenic shock in small animal patients is highly dependent on identifying the underlying physiologic derangement and tailoring therapy appropriately. For those requiring preload, afterload, and contractility support, therapy revolves around fluid restriction, diuretic administration, and positive inotropes such as dobutamine or pimobendan to enhance myocardial contractility (Table 2). Afterload reduction may be achieved with vasodilators such as hydralazine or nitroglycerin in select cases to lower systemic vascular resistance, improving forward flow and cardiac output when blood pressure allows. Oxygen supplementation and gentle sedation are often helpful adjuncts in reducing cardiac workload and distress.

In contrast, patients with cardiogenic shock precipitated or exacerbated by arrhythmias, such as rapid ventricular tachycardia or atrial fibrillation, primarily require stabilization of heart rate and rhythm. Rate reduction may be achieved with vagal maneuvers (e.g., gentle ocular pressure, carotid sinus massage), β-blockers (e.g., esmolol), calcium channel blockers (e.g., diltiazem), or antiarrhythmic agents such as lidocaine or procainamide depending on the specific rhythm disturbance. Increasing rate may respond to anticholinergics (e.g., atropine, glycopyrrolate [Table 2]) or require a pacemaker if medical management fails. Successful rate control reduces myocardial oxygen demand and helps restore effective cardiac output, allowing improved systemic perfusion.

Throughout all forms of cardiogenic shock, aggressive fluid therapy must be avoided to prevent worsening pulmonary edema, and therapy should be guided by frequent reassessment, imaging, and hemodynamic monitoring.

Summary

Shock in small animal patients represents a dynamic and life-threatening failure of tissue perfusion that demands rapid, informed, and adaptable clinical management. Understanding the distinct mechanisms underlying hypovolemic, cardiogenic, obstructive, and distributive shock provides a framework for rational diagnostic and therapeutic decision making. Because animals frequently present with overlapping or evolving shock states, clinicians must rely on a combination of physical examination findings, bedside diagnostics, and response to therapy rather than any single parameter. Early intervention during compensatory or early decompensated phases offers the greatest opportunity for reversal, while delayed recognition markedly worsens prognosis. By maintaining a physiology-based approach, prioritizing continuous reassessment, and applying targeted treatments, veterinary clinicians can significantly improve outcomes for dogs and cats experiencing shock in emergency and critical care settings.